𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia

✍ Scribed by M. Arning; A. H. Heer-Sonderhoff; A. Wehmeier; W. Schneider

Publisher
Springer
Year
1995
Tongue
English
Weight
385 KB
Volume
14
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Refractory Aspergillus pneumonia in pati
Refractory Aspergillus pneumonia in patients with acute leukemia : Successful therapy with combination caspofungin and liposomal amphotericin
✍ Timothy B. Aliff; Peter G. Maslak; Joseph G. Jurcic; Mark L. Heaney; Kathleen N. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

## Abstract ## BACKGROUND Pulmonary aspergillosis and other invasive fungal infections (IFIs) commonly complicate the management of patients with acute leukemia. Standard amphotericin‐based therapies may be ineffective for many patients and the available salvage agents (itraconazole and caspofungi

Liposomal amphotericin B versus the comb
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction : Chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome
✍ Gloria N. Mattiuzzi; Elihu Estey; Issam Raad; Francis Giles; Jorge Cortes; Yu Sh πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 94 KB

## Abstract ## BACKGROUND Fungal infections are a major cause of morbidity and mortality in patients undergoing induction chemotherapy for acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The authors evaluated the efficacy and toxicity of liposomal amphotericin B (L‐AmB) compar

Efficacy and toxicity of caspofungin in
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
✍ Dimitrios P. Kontoyiannis; Ray Hachem; Russell E. Lewis; Gustavo A. Rivero; Harr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Caspofungin (CAS) as salvage therapy for refractory invasive aspergillosis (IA) had a response rate of 45% among a heterogeneous group of patients. The use of CAS with other agents is appealing given its unique mechanism of action. Therefore, the authors retrospectively e